BRANDEN CUTLER: Open Payments
NPI 1346998820 · ROCKLIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 26 payments from 13 companies in 2025. Trend: 2023 $27 · 2024 $256 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $167 |
| Janssen Biotech, Inc. | 2 | $164 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| GENZYME CORPORATION | 2 | $51 |
| Biocon Biologics Inc | 1 | $50 |
| ABBVIE INC. | 2 | $46 |
| PFIZER INC. | 2 | $33 |
| Braintree Laboratories, Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: VOQUEZNA, TREMFYA, XIFAXAN, DUPIXENT, ENTYVIO, Yesintek, EOHILIA, SUTAB.
Industry payments across CA — which companies pay providers there.
